AT289788B - Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze - Google Patents

Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze

Info

Publication number
AT289788B
AT289788B AT483869A AT483869A AT289788B AT 289788 B AT289788 B AT 289788B AT 483869 A AT483869 A AT 483869A AT 483869 A AT483869 A AT 483869A AT 289788 B AT289788 B AT 289788B
Authority
AT
Austria
Prior art keywords
salts
preparation
optically active
active thiadiazole
thiadiazole
Prior art date
Application number
AT483869A
Other languages
English (en)
Original Assignee
Frosst & Co Inc Charles E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frosst & Co Inc Charles E filed Critical Frosst & Co Inc Charles E
Application granted granted Critical
Publication of AT289788B publication Critical patent/AT289788B/de
Priority claimed from US00370994A external-priority patent/US3812182A/en
Priority claimed from US05/417,301 external-priority patent/US3962338A/en
Priority claimed from US425912A external-priority patent/US3892744A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT483869A 1968-05-22 1969-05-21 Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze AT289788B (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US73133368A 1968-05-22 1968-05-22
US81808669A 1969-04-21 1969-04-21
US81809069A 1969-04-21 1969-04-21
US81847469A 1969-04-21 1969-04-21
US17223271A 1971-08-16 1971-08-16
US17223171A 1971-08-16 1971-08-16
US17223071A 1971-08-16 1971-08-16
US17914771A 1971-09-09 1971-09-09
US17914571A 1971-09-09 1971-09-09
US28401372A 1972-08-25 1972-08-25
US00370994A US3812182A (en) 1968-05-22 1973-06-18 S-bis-(2-lower alkyl amino hydroxy-methylethoxy)-methanes
US05/417,301 US3962338A (en) 1968-05-22 1973-11-19 Novel methods and compounds employed therein
US425912A US3892744A (en) 1968-05-22 1973-12-18 Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles

Publications (1)

Publication Number Publication Date
AT289788B true AT289788B (de) 1971-05-10

Family

ID=27584550

Family Applications (3)

Application Number Title Priority Date Filing Date
AT483869A AT289788B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze
AT1063470A AT305229B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von S-1,2-Dihydroxy-3-aminopropan
AT1063570A AT294830B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT1063470A AT305229B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von S-1,2-Dihydroxy-3-aminopropan
AT1063570A AT294830B (de) 1968-05-22 1969-05-21 Verfahren zur Herstellung von 3-X-4-Chlor-1,2,5-thiadiazolen

Country Status (10)

Country Link
US (3) US3657237A (de)
AT (3) AT289788B (de)
BE (1) BE733387A (de)
CA (1) CA949069A (de)
CH (5) CH560710A5 (de)
DE (1) DE1925955A1 (de)
FR (2) FR2039306B1 (de)
GB (2) GB1267328A (de)
NL (1) NL153189B (de)
SE (2) SE388613B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892744A (en) * 1968-05-22 1975-07-01 Merck & Co Inc Process for preparing 4-{8 3-(substituted amino)-2-hydroxypropoxy{9 -1,2,5-thiadiazoles
JPS4913176A (de) * 1972-06-03 1974-02-05
US3891639A (en) * 1973-04-19 1975-06-24 Merck Sharp & Dohme 4-{8 3-Amino-2-acyloxypropoxy{9 -1,2,5-thiadiazole compounds
US4011217A (en) * 1973-04-19 1977-03-08 Merck Sharp & Dohme (I.A.) Corporation 4-(3-amino-2-acyloxypropoxy)-1,2,5-thiadiazole compounds
DE2609486A1 (de) * 1975-08-07 1977-05-12 Hoffmann La Roche Imidazo eckige klammer auf 1,5-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu diazepin-verbindungen und verfahren zu ihrer herstellung
US4097490A (en) * 1975-09-25 1978-06-27 Merck & Co., Inc. Pyroglutamic acid salts of t-butylamino-2,3-dihydroxypropane
US4119718A (en) * 1977-05-02 1978-10-10 Merck & Co., Inc. 3-Amino-2-oxy-propoxy-substituted isothiazoles
ZA805250B (en) * 1979-09-04 1981-09-30 Bristol Myers Co Chemical compounds
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
AU540656B2 (en) * 1980-02-19 1984-11-29 Merck & Co., Inc. S-(-)-1-(tert-butylamino-3((4-morpholino-1,2,5-thiadiazol-3- yl)-oxy)-2-propanol pamoate
US4550117A (en) * 1982-07-26 1985-10-29 Merck & Co., Inc. 3-Cycloalkylamino-2-OR-propoxycyanopyridines, derivatives thereof, having anti-hypertensive activity
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI82240C (fi) * 1988-10-20 1991-02-11 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt vaerdefullt s-timolol-hemihydrat.
US5320839A (en) * 1991-10-11 1994-06-14 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
US5523301A (en) * 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
US5821370A (en) * 1994-10-24 1998-10-13 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
EP1609837B1 (de) * 2003-02-05 2016-11-02 Hitachi Chemical Company, Ltd. Reibungsmaterialzusammensetzung und daraus hergestelltes reibungsmaterial
US7090548B1 (en) * 2005-02-03 2006-08-15 International Business Machines Corporation Method of using a linear propulsor array for propulsion and navigation
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2050441A1 (de) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Verwendung von Beta-Blockern für die Herstellung eines Medikaments zur Behandlung von Hämangiomen
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2964530A (en) * 1958-05-02 1960-12-13 Sterling Drug Inc 3-alkyl-4-hydroxymethyl-4-alkyloxazolidines

Also Published As

Publication number Publication date
CH544119A (de) 1973-12-28
BE733387A (de) 1969-11-21
SE7410837L (de) 1974-08-27
US3781284A (en) 1973-12-25
DE1925955A1 (de) 1970-10-29
FR2116583A1 (de) 1972-07-13
SE388613B (sv) 1976-10-11
CH553214A (de) 1974-08-30
CH554887A (de) 1974-10-15
FR2116583B1 (de) 1982-03-19
NL153189B (nl) 1977-05-16
FR2039306A1 (de) 1971-01-15
CA949069A (en) 1974-06-11
GB1267328A (en) 1972-03-15
US3766180A (en) 1973-10-16
US3657237A (en) 1972-04-18
SE421001B (sv) 1981-11-16
GB1264558A (de) 1972-02-23
CH560710A5 (de) 1975-04-15
FR2039306B1 (de) 1974-03-22
AT305229B (de) 1973-02-12
CH543478A (de) 1973-12-14
AT294830B (de) 1971-12-10
NL6907872A (de) 1969-11-25

Similar Documents

Publication Publication Date Title
AT289788B (de) Verfahren zur Herstellung eines optisch aktiven Thiadiazols und seiner Salze
CH509339A (de) Verfahren zur Herstellung von Thiadiazol-Derivaten
AT299193B (de) Verfahren zur Herstellung von neuen Imidazolidinochinalinderivaten und ihren Salzen
CH511862A (de) Verfahren zur Herstellung von Pyrazinoyl- und Pyrazinamidoguanidinen
AT289107B (de) Verfahren zur Herstellung von 3-Amino-isothiazolen und ihren Salzen
CH522639A (de) Verfahren zur Herstellung von 3-Indolylessigsäurederivaten und deren Salzen
AT287694B (de) Verfahren zur Herstellung von neuen Imidazolindinderivaten und ihren Salzen
CH517750A (de) Verfahren zur Herstellung herbizid aktiver 5-Imino-imidazolidindione und 4-Thio-5-imino-imidazolidindione
CH524623A (de) Verfahren zur Herstellung von Triazaadamantan-Derivaten und deren Verwendung
CH531515A (de) Verfahren zur Herstellung von Dibenzazocinderivaten und von Salzen davon
CH517058A (de) Verfahren zur Herstellung von Alk-1-en-5-onen und Alk-1-en-5-alen
CH475978A (de) Verfahren zur Herstellung von 8-Caprolacton und seiner Alkylderivate
AT291962B (de) Verfahren zur Herstellung eines Salzen aus optisch aktivem Lysin und einer optisch inaktiven Säure
CH520118A (de) Verfahren zur Herstellung eines N-Carbonylfluoralkylsulfonanilids und seine Verwendung
AT260896B (de) Verfahren zur Herstellung eines substituierten p-Phenylendiamins und seiner Salze
AT289773B (de) Verfahren zur Herstellung des neuen β-Naphthylacetamidins und seiner Salze
AT272517B (de) Verfahren zur Herstellung der Natriumsalze von α-Aminobenzylpenicillin und seiner Epimeren
AT312598B (de) Verfahren zur Herstellung von Imidazolderivaten und ihren Salzen
AT287698B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT288375B (de) Verfahren zur Herstellung von neuen Imidazolidinderivaten und ihren Salzen
AT287693B (de) Verfahren zur Herstellung des 4-Benzyl-3-methansulfonamido-2-methyl-1-phenyl-3-pyrazolin-5-ons und seiner Alkalisalze
CH513893A (de) Verfahren zur Herstellung von N-Diaryl-pyridylmethyl-imidazolen und deren Salzen
AT289064B (de) Verfahren zur Herstellung des neuen (-)-(m-Chlor-α-methylphenäthyl)-sulfamids und seiner Salze
AT302312B (de) Verfahren zur Herstellung von 3-Methoxy-2-sulfanylamido-pyrazin und dessen Salzen
AT278776B (de) Verfahren zur herstellung von 2-(halogenphenylamino)-imidazolin-2-derivaten und ihren salzen